US Patent Issued to ST. JOHN'S UNIVERSITY on Oct. 21 for "Circulating serum microRNA biomarkers and methods for Parkinson's disease prognosis" (New York Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,448,653, issued on Oct. 21, was assigned to ST. JOHN'S UNIVERSITY (Queens, N.Y.).

"Circulating serum microRNA biomarkers and methods for Parkinson's disease prognosis" was invented by Simon Geir Moller (Queens, N.Y.), Indranil Basak (Queens, N.Y.), Ketan Patil (Queens, N.Y.), Jan Petter Larsen (Queens, N.Y.) and Guido Werner Alves (Queens, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides biomarkers and methods for identifying, verifying and confirming circulating serum-based microRNAs. The microRNAs (PrognomiRs) can be used to differentiate patient's suffering from rapid progressing Parkinson's disease (PD) from slow progressin...